Fellowship · Boston, MA
Sponsored by Boston Children's Hospital
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Nature medicine · 2025 · 143 citations · Carmen Astudillo
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.
American journal of respiratory and critical care medicine · 2023 · 253 citations · Erick Forno, Robyn Cohen
Current clinical applications of AAV-mediated gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy · 2025 · 87 citations · Carmen Astudillo
Disparities in Sleep Health and Potential Intervention Models: A Focused Review.
Chest · 2021 · 225 citations · Robyn Cohen
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies.
The Journal of clinical investigation · 2024 · 115 citations · Carmen Astudillo
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
The Lancet. Respiratory medicine · 2023 · 109 citations ·
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023 · 120 citations · Erick Forno
Age-related changes in gait biomechanics and their impact on the metabolic cost of walking: Report from a National Institute on Aging workshop.
Experimental gerontology · 2023 · 86 citations · Gregory Sawicki